Features

Features

ASCO26 Podcast: an analyst rundown of the best readouts and key trends

While the 2026 American Society of Clinical Oncology (ASCO) conference may be over for another year, the editorial team at…

Annabel Kartal Allen

Features

FDA leadership in flux, but core operations remain stable, former FDA staff say

Features

Podcast: Experience as a patient in a first-in-human clinical trial

Features

H1 2026 clinical trials: China, funding and technology set the agenda

Features

Participant enrolment and retention key to clinical trial derisking

Features

Three PsA trials to watch in 2026

Features

Podcast: UK targets speedy clinical trial set-ups with 150-day benchmark

Features

Countries compete to reform trials in a bid to attract global sponsors

Features

Implementing AI in workflows: One step at a time

Features

Despite turbulence at FDA, technical staff remain “dedicated,” says CMO

Features

Wave of AI and data science tools set to transform clinical trials

Features

EU’s Joint Clinical Assessment system still finding its footing

Features

The slow march of clinical biomarkers to become surrogate endpoints

Frankie Fattorini

Features

Biomarker-led trials to guide the future of precision psychiatry

Annabel Kartal Allen

Features

Preparation is key to understanding global trade compliance for trials

Features

Trials to watch: Phase III TB vaccines and MDR-TB treatments

Features

Technology a key tool in successful clinical supply management

Features

Strong relationships among stakeholders key to clinical supply chain success

Features

Be nimble, be ready: how to tackle regulatory uncertainty in clinical trials

Features

Building for decades: Dubai’s long game in life sciences

Catherine Longworth

Features

Opening clinical trials to pregnant women

Features

Women first: the Gulf’s new healthcare blueprint

Catherine Longworth

Features

The clinical trial supply model of the future

Features

Podcast: Sanofi’s head of clinical supply chain operations on evolving the clinical trial supply model

Features

Podcast: Rare Disease Day: FDA guidance allowing advancement

Abigail Beaney , Robert Barrie and Frankie Fattorini

Features

Rare disease developers applaud clarity in FDA guidance

Features

The Bayesian challenge: complexity that pays off

Features

How new technologies could transform clinical trial execution

Features

Magazine: Smart and connected packaging

Features

SLE: four trials to watch in 2026

Annabel Kartal Allen

Features

Trial acceleration: AI supports progress, relationships drive success

News

Speech biomarkers offer new lease of life to patient experience and trial retention

Annabel Kartal Allen

Features

Podcast: Healthcare’s biggest 2025 trends and 2026 predictions

Features

Pharma positions itself for 2026 amid an evolving US landscape

Features

AI takes charge of data, but challenges linger

Features

APAC’s rising stars beyond China

Features

OCT DACH 2025: Geopolitics, trial equity and technology take centre stage

Annabel Kartal Allen

Features

Public sector R&D cuts could be the “silent economic killers” of US exceptionalism

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close